SEATTLE, WA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Pure Global Cannabis, Inc (TSXV: PURE) (OTC: PRCNF) and its wholly-owned subsidiary, PureSinse Inc, taking the reins with aspirations of becoming the leader in the cannabis health & wellness industry on both the Canadian and the international fronts.
The health and wellness industry, in general, has experienced growing interest in the past few years. Baby boomers, who make up 70% of wellness industry consumers, are seeking alternatives to help improve their quality of life and prevent conditions related to aging. Additionally, members of Generation Z (the under 20-year-olds), are driving demand for alternative and more natural ways of achieving and maintaining wellness without using industrialized pharmaceuticals. Techniques that involve mindfulness, meditation, yoga, and general fitness are gaining popularity and consumers across both generations are now looking to add cannabis products to their health and wellness arsenal.
In the 12 years since medical cannabis has been legal in Canada, it has become increasingly clear cannabis is one of the most powerful medicinal plants known to man - not as only a treatment, but also as a preventative. With over 22,000 scientific studies on the medical use of cannabis, over 100 phytocannabinoid compounds have been discovered and more are uncovered each year. Each of these cannabinoids acts uniquely through CB1 and CB2 receptors, which make up the Endocannabinoid system. The Endocannabinoid system is comprised of a series of receptors in the human brain and body that respond pharmacologically to cannabis and have been discovered to play a crucial role in regulating our physiology. There has also been subsequent identification of endogenous cannabinoid compounds in the mammalian brain and body that bind to these receptors and this has significantly advanced the scientific understanding of human biology, health, and disease.
There is mounting evidence, for example, that those who use cannabis prior to working out can reduce anxiety, increase their pain threshold (more reps) and get into an aerobic zone. Those who use cannabis after their workout may find that it can help reduce inflammation, relieve pain, increase mass, and help them sleep better. To capture the attention of these pivotal markets, the family of products currently being developed by PureSinse are specially formulated to supplement lifestyles for better fitness, health, and wellbeing.
Health and Wellness Cannabis Products
The PureSinse team of professionals have been striving to unlock the medical secrets of cannabis that provide the most benefit to a given condition, or for a given individual. Pure Global is committed to creating unique delivery methods and formulations in cannabis pharmaceuticals that will treat chronic diseases, psychological and neurological disorders, and a myriad of other health and wellness applications.
Additionally, once adult use cannabis is legalized in Canada in the fall of 2018, further development of cannabis-infused health and beauty products are strongly anticipated to garner more interest from consumers. Dispensaries and retail outlets are expected to dedicate entire sections of OTC products for pain relief, skin care, nutraceuticals, and food & beverage related health and wellness products.
Cannabis tonics, juices, teas, smoothies, and trendy cocktails are also gaining popularity in the mainstream markets, along with gourmet edibles, confections, baked goods, and cannabis-infused cooking oils. In certain states where adult use is legal in the U.S.A, cannabis communities are growing rapidly. Cannabis crafting workshops, cannabis-inspired dining establishments, and cannabis health challenges are all making cannabis more accessible and appealing to consumers of all types.
Looking Ahead
Pure Global will soon begin selling dried flower and cannabis oils, followed by softgels and capsules, sublingual sprays, edibles, and wellness products when they become legal in 2019. With a strong focus on developing the highest quality products, the company is positioning itself to obtain EU Good Manufacturing Practice (GMP) and ISO certifications for both domestic and international markets. Such a certification of the company’s facilities and processes is essential to achieve its strategy of expanding commercial operations to South America, Europe, Australia, and Asia.
As a growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural and supply chain experts, the Pure Global portfolio will feature a wide spectrum of brands, products, formulations, and infusions for both the medical and adult-use markets, at home and abroad.
For more information, visit the company’s website
Please follow the link to read the full article: http://www.cannabisfn.com/?p=1242132&preview_id=1242132&preview_nonce=2c015897ad&_thumbnail_id=912332&preview=true
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided onhttp://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/